Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Vivos Therapeutics Reports Full Year 2025 Financial Results Full Year 2025 revenue increased 16%
-
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call
-
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
-
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare
-
Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy
-
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies
-
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
-
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds
-
Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan
-
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST